(Q43067451)

13 November 2017

1 reference

title

The current status of heroin prescription treatment for heroin dependence (English)

1 reference

13 November 2017

1

Alex Wodak

0 references

author name string

Alex Wodak

series ordinal

1

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Expert Opinion on Drug Safety

13 November 2017

published in

1 reference

13 November 2017

volume

4

1 reference

13 November 2017

issue

5

1 reference

13 November 2017

page(s)

815-819

1 reference

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Cost-benefit analysis of drug treatment services: review of the literature*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Heroin-assisted treatment as a response to the public health problem of opiate dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Prescription of heroin to treatment resistant heroin addicts: heroin handouts are flawed policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

The Swiss heroin trials. Scientifically sound?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

The ethics of experimental heroin maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.815

21 January 2018

Identifiers

DOI

10.1517/14740338.4.5.815

1 reference

13 November 2017

1 reference